Novartis Investigative Site

Aarau, CH 5001

0 studies enrolling now · 1 studies all time

What they study most

Secondary Progressive Multiple Sclerosis

Studies at this site

• Exploring the Efficacy and Safety of Siponimod in Patients With Secondary Progressive Multiple Sclerosis (EXPAND) — Completed